华西口腔医学杂志

• 临床研究 • 上一篇    下一篇

口服咪达唑仑治疗牙科恐惧症儿童的临床疗效观察

马林 景泉 万阔   

  1. 中国医学科学院北京协和医学院北京协和医院口腔科, 北京100730
  • 收稿日期:2012-06-25 修回日期:2012-06-25 出版日期:2012-06-01 发布日期:2012-06-01
  • 通讯作者: 万阔,Tel:010-65295256
  • 作者简介:马林(1978—),女,河南人,主治医师,硕士
  • 基金资助:

    美国中华医学基金会基金资助项目(A350600)

Evaluation of oral midazolam sedation for reducing dental fear in children with dental fear

Ma Lin, Jing Quan, Wan Kuo   

  1. Dept. of Stomatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
  • Received:2012-06-25 Revised:2012-06-25 Online:2012-06-01 Published:2012-06-01
  • Contact: Wan Kuo,Tel:010-65295256
  • About author:Ma Lin(1978—),女,河南人,主治医师,硕士

摘要:

目的对牙科恐惧症儿童实施口服咪达唑仑镇静下的口腔治疗,评估治疗的安全性、有效性及其影响因素。方法选择在口腔科就诊的Frankl量表评分为1的有不良牙科治疗经历的30例患儿为研究对象,共进行了46人次的口服咪达唑仑(0.5~1.0 mg·kg-1)镇静下治疗。治疗时,记录患儿的心率、血氧饱和度、治疗内容及持续时间等。采用Houpt量表评估患儿治疗完成情况,治疗结束24 h后电话回访不良反应。结果46人次治疗中,患儿的生命体征平稳、安全,37人次(80.4%)完成了既定治疗,9人次(19.6%)镇静效果不理想,仅完成部分治疗。烦躁不安是术后最常见的不良反应。3岁以上儿童的治疗成功率高于3岁及以下儿童,性别、剂量和治疗内容与治疗成功率无关。结论口服咪达唑仑治疗牙科恐惧症儿童是一种安全有效的方法,3岁以上儿童的治疗效果较好。

关键词: 牙科恐惧, 咪达唑仑, 镇静, 儿童, 不良牙科经历

Abstract:

Objective To assess the safety, effectiveness and influential factors of oral midazolam sedation for reducing dental fear in children with dental fear. Methods 30 children with traumatic dental experience, who were classified as 1 by Frankl behavior rating scale, were included in the study. Each child was treated under sedation with oral midazolam(0.5-1.0 mg·kg-1), and totally 46 person-time sedation treatments were conducted. At each visit, heart rate, arterial oxygen saturation, persistent period and treatment types were recorded. Treatment performed was rated by Houpt scale. Telephone following up was performed to record the side effects 24 h after treatment. Results In all of the 46 person-time treatments, the heart rate, arterial oxygen saturation levels were within acceptable clinical limits. 37 person-time planned treatments(80.4%) were completed satisfactorily. Oral sedation was ineffective in 9 person-time treatments(19.6%), and only a part of planned treatments were completed. Dysphoria after treatment is the main side effect. Children over 3 years old had a high success rate than those under 3 years old. And the success rate of treatment had no relation with sex, dose and treatment types. Conclusion Oral midazolam could be a safe and acceptable approach of sedation for pediatric dental patients with dental fear, especially to the children over
3 years old.

Key words: dental fear, midazolam, sedation, children, traumatic dental experience